New research published in the Journal of Psychopathology and Clinical Science suggests that how quickly and frequently we ...

While discussing his plans for a physical, President Trump once again bragged about the score he achieved on his last ...

The US Food and Drug Administration has given clearance to another blood test to help assess Alzheimer’s disease and other ...

The availability of a rule-in-rule-out test for Alzheimer’s disease in primary care settings is likely to drive efficiencies throughout the care continuum.

A second blood test has been been approved by the US Food and Drug Administration to assist in diagnosing Alzheimer’s disease ...

The FDA has granted 510(k) clearance to a blood-based biomarker test indicated for early detection of Alzheimer’s disease and other causes of cognitive decline within a primary care setting, according ...

The information on this website may assist you in making personal decisions about insurance, but it is not intended to provide advice regarding the purchase or use of any insurance or insurance ...

Increasing social media usage among children has been linked to a decline in cognitive performance. A JAMA study involving ...

Cognitive performance was similar among four glucose-lowering medications in the GRADE trial. Higher HbA1c levels were linked to modestly lower cognitive test scores. Findings may provide important ...

A new MyIQ survey suggests that as cognitive screening becomes more common in hiring, job seekers are responding with drills, ...

President Donald Trump insists he is in “great shape” with no signs of cognitive impairment as speculation over his health ...

During his remarks in a meeting with the President of Finland yesterday, President Trump admitted that he struggled while taking a cognitive test. Trump stated, "It was not the easiest test." ...